Literature DB >> 34585293

Four pedigrees with aminoacyl-tRNA synthetase abnormalities.

Nobuhiko Okamoto1, Fuyuki Miya2,3,4, Tatsuhiko Tsunoda2,3,4, Yonehiro Kanemura5,6, Shinji Saitoh7, Mitsuhiro Kato8, Kumiko Yanagi9, Tadashi Kaname9, Kenjiro Kosaki10.   

Abstract

Aminoacyl tRNA synthetases (ARSs) are highly conserved enzymes that link amino acids to their cognate tRNAs. Thirty-seven ARSs are known and their deficiencies cause various genetic disorders. Variants in some ARSs are associated with the autosomal dominant inherited form of axonal neuropathy, including Charcot-Marie-Tooth (CMT) disease. Variants of genes encoding ARSs often cause disorders in an autosomal recessive fashion. The clinical features of cytosolic ARS deficiencies are more variable, including systemic features. Deficiencies of ARSs localized in the mitochondria are often associated with neurological disorders including Leigh and early-onset epileptic syndromes. Whole exome sequencing (WES) is an efficient way to identify the genes causing various symptoms in patients. We identified 4 pedigrees with novel compound heterozygous variants in ARS genes (WARS1, MARS1, AARS2, and PARS2) by WES. Some unique manifestations were noted. The number of patients with ARSs has been increasing since the application of WES. Our findings broaden the known genetic and clinical spectrum associated with ARS variants.
© 2021. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  AARS2; Aminoacyl tRNA synthetases; MARS1; PARS2; WARS1

Mesh:

Substances:

Year:  2021        PMID: 34585293     DOI: 10.1007/s10072-021-05626-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  41 in total

1.  A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N).

Authors:  Heather M McLaughlin; Reiko Sakaguchi; William Giblin; Thomas E Wilson; Leslie Biesecker; James R Lupski; Kevin Talbot; Jeffery M Vance; Stephan Züchner; Yi-Chung Lee; Marina Kennerson; Ya-Ming Hou; Garth Nicholson; Anthony Antonellis
Journal:  Hum Mutat       Date:  2011-11-09       Impact factor: 4.878

2.  Loss-of-function alanyl-tRNA synthetase mutations cause an autosomal-recessive early-onset epileptic encephalopathy with persistent myelination defect.

Authors:  Cas Simons; Laurie B Griffin; Guy Helman; Gretchen Golas; Amy Pizzino; Miriam Bloom; Jennifer L P Murphy; Joanna Crawford; Sarah H Evans; Scott Topper; Matthew T Whitehead; John M Schreiber; Kimberly A Chapman; Cyndi Tifft; Katrina B Lu; Howard Gamper; Megumi Shigematsu; Ryan J Taft; Anthony Antonellis; Ya-Ming Hou; Adeline Vanderver
Journal:  Am J Hum Genet       Date:  2015-03-26       Impact factor: 11.025

3.  A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivo.

Authors:  Aimée Vester; Gisselle Velez-Ruiz; Heather M McLaughlin; James R Lupski; Kevin Talbot; Jeffery M Vance; Stephan Züchner; Ricardo H Roda; Kenneth H Fischbeck; Leslie G Biesecker; Garth Nicholson; Asim A Beg; Anthony Antonellis
Journal:  Hum Mutat       Date:  2012-10-11       Impact factor: 4.878

4.  Cysteinyl-tRNA Synthetase Mutations Cause a Multi-System, Recessive Disease That Includes Microcephaly, Developmental Delay, and Brittle Hair and Nails.

Authors:  Molly E Kuo; Arjan F Theil; Anneke Kievit; May Christine Malicdan; Wendy J Introne; Thomas Christian; Frans W Verheijen; Desiree E C Smith; Marisa I Mendes; Lidia Hussaarts-Odijk; Eric van der Meijden; Marjon van Slegtenhorst; Martina Wilke; Wim Vermeulen; Anja Raams; Catherine Groden; Shino Shimada; Rebecca Meyer-Schuman; Ya Ming Hou; William A Gahl; Anthony Antonellis; Gajja S Salomons; Grazia M S Mancini
Journal:  Am J Hum Genet       Date:  2019-02-26       Impact factor: 11.025

5.  Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy.

Authors:  Albena Jordanova; Joy Irobi; Florian P Thomas; Patrick Van Dijck; Kris Meerschaert; Maarten Dewil; Ines Dierick; An Jacobs; Els De Vriendt; Velina Guergueltcheva; Chitharanjan V Rao; Ivailo Tournev; Francisco A A Gondim; Marc D'Hooghe; Veerle Van Gerwen; Patrick Callaerts; Ludo Van Den Bosch; Jean-Pièrre Timmermans; Wim Robberecht; Jan Gettemans; Johan M Thevelein; Peter De Jonghe; Ivo Kremensky; Vincent Timmerman
Journal:  Nat Genet       Date:  2006-01-22       Impact factor: 38.330

6.  Mutations in RARS cause hypomyelination.

Authors:  Nicole I Wolf; Gajja S Salomons; Richard J Rodenburg; Petra J W Pouwels; Jolanda H Schieving; Terry G J Derks; Johanna M Fock; Patrick Rump; Daphne M van Beek; Marjo S van der Knaap; Quinten Waisfisz
Journal:  Ann Neurol       Date:  2014-05-16       Impact factor: 10.422

7.  Mutations in RARS cause a hypomyelination disorder akin to Pelizaeus-Merzbacher disease.

Authors:  Michael Nafisinia; Nara Sobreira; Lisa Riley; Wendy Gold; Birgit Uhlenberg; Claudia Weiß; Corinne Boehm; Kristina Prelog; Robert Ouvrier; John Christodoulou
Journal:  Eur J Hum Genet       Date:  2017-07-26       Impact factor: 4.246

8.  Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V.

Authors:  Anthony Antonellis; Rachel E Ellsworth; Nyamkhishig Sambuughin; Imke Puls; Annette Abel; Shih-Queen Lee-Lin; Albena Jordanova; Ivo Kremensky; Kyproula Christodoulou; Lefkos T Middleton; Kumaraswamy Sivakumar; Victor Ionasescu; Benoit Funalot; Jeffery M Vance; Lev G Goldfarb; Kenneth H Fischbeck; Eric D Green
Journal:  Am J Hum Genet       Date:  2003-04-10       Impact factor: 11.025

9.  A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease.

Authors:  Philippe Latour; Christel Thauvin-Robinet; Chantal Baudelet-Méry; Pierre Soichot; Veronica Cusin; Laurence Faivre; Marie-Claire Locatelli; Martine Mayençon; Annie Sarcey; Emmanuel Broussolle; William Camu; Albert David; Robert Rousson
Journal:  Am J Hum Genet       Date:  2009-12-31       Impact factor: 11.025

10.  Mutations in DARS cause hypomyelination with brain stem and spinal cord involvement and leg spasticity.

Authors:  Ryan J Taft; Adeline Vanderver; Richard J Leventer; Stephen A Damiani; Cas Simons; Sean M Grimmond; David Miller; Johanna Schmidt; Paul J Lockhart; Kate Pope; Kelin Ru; Joanna Crawford; Tena Rosser; Irenaeus F M de Coo; Monica Juneja; Ishwar C Verma; Prab Prabhakar; Susan Blaser; Julian Raiman; Petra J W Pouwels; Marianna R Bevova; Truus E M Abbink; Marjo S van der Knaap; Nicole I Wolf
Journal:  Am J Hum Genet       Date:  2013-05-02       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.